Search Results - "Tenali Gnana, Sagar"

Refine Results
  1. 1
  2. 2

    Nonadherence to Imatinib adversely affects event free survival in chronic phase chronic myeloid leukemia by Ganesan, Prasanth, Sagar, Tenali Gnana, Dubashi, Biswajit, Rajendranath, Rejiv, Kannan, Krishnarathinam, Cyriac, Sanju, Nandennavar, Manjunath

    Published in American journal of hematology (01-06-2011)
    “…There is limited data on the impact of treatment interruptions due to nonadherence in patients with chronic phase chronic myeloid leukemia (CP‐CML) treated…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Factors that impact the outcomes in testicular germ cell tumors in low–middle-income countries by Saju, S. V., Radhakrishnan, Venkatraman, Ganesan, Trivadi S., Dhanushkodi, Manikandan, Raja, Anand, Selvaluxmy, Ganesarajah, Sagar, Tenali Gnana

    “…Germ cell tumors (GCTs) are one of the most common tumors in adolescents and young adults. There is paucity of data on GCT from low–middle-income countries…”
    Get full text
    Journal Article
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Autologous Stem Cell Transplantation in Testicular Germ Cell Tumor—Preliminary Experience from a Single Center by Selvarajan, Gangothri, Jayachandran, Perumal Kalaiyarasi, Rajan, Arun Kumar, Kesana, Sivashree, Kannan, Krishnarathinam, Sagar, Tenali Gnana, Ganesan, Trivadi Sundaram

    Published in South Asian journal of cancer (01-04-2021)
    “…Abstract Background Germ cell tumor (GCT) of the testis is one of the highly curable solid organ malignancies. Those who experience relapse after…”
    Get full text
    Journal Article
  13. 13

    Acute Lymphoblastic Leukemia in Young Adults Treated with Intensive “Pediatric” Type Protocol by Ganesan, Prasanth, Sagar, Tenali Gnana, Kannan, Krishnarathinam, Radhakrishnan, Venkatraman, Dhanushkodi, Manikandan, Swaminathan, Rajaraman, Sundersingh, Shirley, Ganesan, Trivadi S.

    “…Young adults with acute lymphoblastic leukemia do better when treated on “pediatric” protocols. Young adults (18–30 years) with Ph-negative ALL treated between…”
    Get full text
    Journal Article
  14. 14

    Oral etoposide and cyclophosphamide: A low-cost palliative metronomic chemotherapy in advanced pediatric cancers by Kumar, Kiran, Radhakrishnan, Venkatraman, Dhanushkodi, Manikandan, Kalaiyarasi, Jayachandran, Mehra, Nikita, Kumar, Arun, Selvarajan, Gangothri, Ganesan, Trivadi, Sagar, Tenali

    “…Introduction: Oral metronomic chemotherapy (OMC) is a less intensive and cost-effective palliative treatment modality in children with relapsed/refractory…”
    Get full text
    Journal Article
  15. 15

    Chronic Myeloid Leukemia: Long-Term Outcome Data in the Imatinib Era by Ganesan, Prasanth, Ganesan, Trivadi S., Radhakrishnan, Venkatraman, Sagar, Tenali Gnana, Kannan, Krishnarathinam, Dhanushkodi, Manikandan, Kalayarasi, Jayachandran Perumal, Mehra, Nikita

    “…Recent reports suggest that in the TKI era, the survival of chronic myeloid leukemia approaches that of general population. The real-world situation may be…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Experience with the Use of Nilotinib in Indian Patients by Manuprasad, Avaronnan, Ganesan, Prasanth, Ganesan, Trivadi S., Radhakrishnan, Venkatraman, Dhanushkodi, Manikandan, Mani, Samson, Sagar, Tenali Gnana

    “…Important genetic and ethnic factors could affect the toxicity and efficacy of tyrosine kinase inhibitors. Though nilotinib has been available in India since…”
    Get full text
    Journal Article
  18. 18

    Outcomes of Oral Metronomic Therapy in Patients with Lymphomas by Mailankody, Sharada, Ganesan, Prasanth, Joshi, Archit, Ganesan, Trivadi S., Radhakrishnan, Venkatraman, Dhanushkodi, Manikandan, Mehra, Nikita, Kalaiyarasi, Jayachandran Perumal, Kannan, Krishnarathinam, Sagar, Tenali Gnana

    “…Oral Metronomic chemotherapy (OMC) is used in patients with lymphoma who may not tolerate intravenous chemotherapy or have refractory disease. It is cheaper,…”
    Get full text
    Journal Article
  19. 19

    DA-EPOCH-R in Aggressive CD 20 Positive B Cell Lymphomas: Real-World Experience by Ganesan, Prasanth, Ganesan, Trivadi S., Atreya, Harshvardhan, Kannan, Krishnarathinam, Radhakrishnan, Venkatraman, Dhanushkodi, Manikandan, Joshua, Thanda Lucy Ann, Sundersingh, Shirley, Sagar, Tenali Gnana

    “…Recent reports have shown that excellent survival outcomes can be achieved in adult Burkitt’s lymphoma with the use of DA-EPOCH-R regimen. When compared to…”
    Get full text
    Journal Article
  20. 20